| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $452.8M | — | +25.2% |
| R&D Expense | $79.6M | — | +7.8% |
| SG&A Expense | $55.1M | — | +4.4% |
| Operating Income | $53.7M | — | +339.3% |
| Pre-tax Income | $52.1M | — | +248.5% |
| Income Tax | $3.0M | — | -15.8% |
| Net Income | $49.1M | — | +332.1% |
| EPS (Basic) | $0.23 | — | +283.3% |
| EPS (Diluted) | $0.23 | — | +360.0% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $649.1M | +19.7% | +31.4% |
| Current Assets | $1.25B | -5.2% | +27.5% |
| Total Assets | $1.39B | -5.0% | +25.9% |
| Current Liabilities | $439.4M | +10.1% | +24.8% |
| Long-term Debt | $0 | -100.0% | — |
| Total Liabilities | $478.3M | -18.9% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $81.9M | — | -38.4% |
| Capital Expenditures | $6.0M | — | -57.1% |
| Investing Cash Flow | -$13.7M | — | +18.7% |
| Financing Cash Flow | $39.1M | — | +453.1% |
| Free Cash Flow | $75.9M | — | -36.2% |
| +26.8% |
| Stockholders' Equity | $907.4M | +4.4% | +25.4% |